Funding from Venture Capital and Private Equity firms
Latest trademark applications
Additional industries in which the company operates
DBA APPLIED ORDINANCE TECHNOLOGIES DBA CENTER FOR MONITORING RESEARCH DBA CLASSIFIED OPERATIONS INDIANAPOLIS DBA CUSTOMER SECTOR DBA DATA SYSTEMS & SOLUTIONS DBA DEFENSE SOLUTIONS GROUP DBA ENTERPRISE DBA EXCEL DBA GOVERNMENT CONTRACT SUPPORT DBA GSA SCHEDULE DBA GSA SCHEDULE - GSA SCHEDULE - NSS DBA GSA SCHEDULE - GSA SCHEDULE - SURVEILLANCE AND RECONNAISSANCE DBA GSA SCHEDULE - NSS DBA HEALTH AND ENGINEERING DBA HEALTH AND ENGINEERING SECTOR DBA INTELLIGENCE SYSTEMS DBA JETTA OPERATIONS DBA JULLIEN DIV DBA MAJOR PROGRAMS DBA MISSION SUPPORT DBA MISSION SUPPORT SEGMENT SERVICES DBA NATIONAL SECURITY DBA NATIONAL SECURITY SECTOR DBA N S S DBA NSS, HEALTH AND ENGINEERING DBA PIEDMONT DBA REVEAL IMAGING DBA SAIC DBA SAIC GOVERNMENT SOLUTIONS DBA SCIENCE APPLICATIONS INTERNATIONAL CORPORATION DBA SCIENTECH ENGINEERING DIV DBA SECURITY DBA SRG DBA SURVEILLANCE AND RECONNAISSANCE DBA SYSTEMS AND TECHNOLOGIES
Leidos's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Research & Development in the Physical, Engineering & Life Sciences industry.
Note: Leidos's revenues are gauged from an analysis of company filings.
Trademark applications show the products and services that Leidos is developing and marketing.
Leidos's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
PROPASSAGE Conveyor system; secure conveyor system; automatic tray feeder and return system comprised of rollers and conveyor belts for use with carry-on checked baggage scanners
BITIDE Pharmaceutical peptide preparations for use in treating cancer, infectious diseases, and central nervous system disorders, consisting of peptide-based PD1 blockade inhibitors linked together by a molecular spacer to create a Bi-Specific Drug, used in combination with recombinant vaccines
CAREC2 QUANTUM Providing temporary use of on-line non-downloadable cloud computing software for use in workforce forecasting, gap analysis and staff management in the field of healthcare
Determine whether Leidos grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Leidos is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
A competitive analysis shows these companies are in the same general field as Leidos, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are in the same general field as Leidos and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.